How the histological structure of some lung cancers shaped almost 70 years of radiobiology

Grubbé EH. Priority in the therapeutic use of X-rays. Radiology. 1933;21:156–62.

Google Scholar 

Gray LH, Conger AD, Ebert M, Hornsey S, Scott OC. The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy. Br J Radiol. 1953;26:638–48.

CAS  PubMed  Google Scholar 

Thomlinson RH, Gray LH. The histological structure of some human lung cancers and the possible implications for radiotherapy. Br J Cancer. 1955;9:539–49.

CAS  PubMed  PubMed Central  Google Scholar 

Mottram J. A factor of importance in the radio sensitivity of tumours. Br J Radiol. 1936;9:606–14.

Google Scholar 

Hollcroft JW, Lorenz E, Matthews M. Factors modifying the effect of X-irradiation on regression of a transplanted lymphosarcoma. J Natl Cancer Inst. 1952;12:751–63.

CAS  PubMed  Google Scholar 

Steel GG, McMillan TJ, Peacock JH. The 5Rs of radiobiology. Int J Radiat Biol. 1989;56:1045–8.

CAS  PubMed  Google Scholar 

Hall EJ, Giaccia AJ. Radiobiology for the radiologist. 8th Edition ed. Philadelphia: Wolters Kluwer; 2019.

Grimes DR, Partridge M. A mechanistic investigation of the oxygen fixation hypothesis and oxygen enhancement ratio. Biomed Phys Eng Express. 2015;1:045209.

PubMed  PubMed Central  Google Scholar 

Jing X, Yang F, Shao C, Wei K, Xie M, Shen H, et al. Role of hypoxia in cancer therapy by regulating the tumor microenvironment. Mol Cancer. 2019;18:157.

PubMed  PubMed Central  Google Scholar 

Lyng H, Sundfør K, Rofstad EK. Oxygen tension in human tumours measured with polarographic needle electrodes and its relationship to vascular density, necrosis and hypoxia. Radiother Oncol. 1997;44:163–9.

CAS  PubMed  Google Scholar 

Vaupel P, Höckel M, Mayer A. Detection and characterization of tumor hypoxia using pO2 histography. Antioxid Redox Signal. 2007;9:1221–35.

CAS  PubMed  Google Scholar 

Eustace A, Irlam JJ, Taylor J, Denley H, Agrawal S, Choudhury A, et al. Necrosis predicts benefit from hypoxia-modifying therapy in patients with high risk bladder cancer enrolled in a phase III randomised trial. Radiother Oncol. 2013;108:40–7.

PubMed  PubMed Central  Google Scholar 

Gross MW, Karbach U, Groebe K, Franko AJ, Mueller-Klieser W. Calibration of misonidazole labeling by simultaneous measurement of oxygen tension and labeling density in multicellular spheroids. Int J Cancer. 1995;61:567–73.

CAS  PubMed  Google Scholar 

Le Q-T, Courter D. Clinical biomarkers for hypoxia targeting. Cancer Metastasis Rev. 2008;27:351–62.

CAS  PubMed  PubMed Central  Google Scholar 

Fleming IN, Manavaki R, Blower PJ, West C, Williams KJ, Harris AL, et al. Imaging tumour hypoxia with positron emission tomography. Br J Cancer. 2015;112:238–50.

CAS  PubMed  Google Scholar 

Huang Y, Fan J, Li Y, Fu S, Chen Y, Wu J. Imaging of tumor hypoxia with radionuclide-labeled tracers for PET. Front Oncol. 2021;11:3547.

Bowen SR, van der Kogel AJ, Nordsmark M, Bentzen SM, Jeraj R. Characterization of positron emission tomography hypoxia tracer uptake and tissue oxygenation via electrochemical modeling. Nucl Med Biol. 2011;38:771–80.

CAS  PubMed  PubMed Central  Google Scholar 

Hammond EM, Asselin MC, Forster D, O’Connor JPB, Senra JM, Williams KJ. The Meaning, measurement and modification of hypoxia in the laboratory and the clinic. Clin Oncol. 2014;26:277–88.

CAS  Google Scholar 

Walsh JC, Lebedev A, Aten E, Madsen K, Marciano L, Kolb HC. The clinical importance of assessing tumor hypoxia: relationship of tumor hypoxia to prognosis and therapeutic opportunities. Antioxid Redox Signal. 2014;21:1516–54.

CAS  PubMed  PubMed Central  Google Scholar 

Semenza GL. HIF-1 and mechanisms of hypoxia sensing. Curr Opin Cell Biol. 2001;13:167–71.

CAS  PubMed  Google Scholar 

Baba Y, Nosho K, Shima K, Irahara N, Chan AT, Meyerhardt JA, et al. HIF1A overexpression is associated with poor prognosis in a cohort of 731 colorectal cancers. Am J Pathol. 2010;176:2292–301.

CAS  PubMed  PubMed Central  Google Scholar 

Goethals L, Debucquoy A, Perneel C, Geboes K, Ectors N, De Schutter H, et al. Hypoxia in human colorectal adenocarcinoma: comparison between extrinsic and potential intrinsic hypoxia markers. Int J Radiat Oncol Biol Phys. 2006;65:246–54.

CAS  PubMed  Google Scholar 

Kaanders JH, Wijffels KI, Marres HA, Ljungkvist AS, Pop LA, van den Hoogen FJ, et al. Pimonidazole binding and tumor vascularity predict for treatment outcome in head and neck cancer. Cancer Res. 2002;62:7066–74.

CAS  PubMed  Google Scholar 

Buffa FM, Harris AL, West CM, Miller CJ. Large meta-analysis of multiple cancers reveals a common, compact and highly prognostic hypoxia metagene. Br J Cancer. 2010;102:428–35.

CAS  PubMed  PubMed Central  Google Scholar 

Bolland H, Ma TS, Ramlee S, Ramadan K, Hammond EM. Links between the unfolded protein response and the DNA damage response in hypoxia: a systematic review. Biochem Soc Trans. 2021;49:1251–63.

CAS  PubMed  PubMed Central  Google Scholar 

Bader SB, Dewhirst MW, Hammond EM. Cyclic hypoxia: an update on its characteristics, methods to measure it and biological implications in cancer. Cancers. 2020;13:23.

Nordsmark M, Bentzen SM, Rudat V, Brizel D, Lartigau E, Stadler P, et al. Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study. Radiother Oncol. 2005;77:18–24.

PubMed  Google Scholar 

Le QT, Chen E, Salim A, Cao H, Kong CS, Whyte R, et al. An evaluation of tumor oxygenation and gene expression in patients with early stage non-small cell lung cancers. Clin Cancer Res. 2006;12:1507–14.

CAS  PubMed  Google Scholar 

Lyng H, Sundfør K, Tropé C, Rofstad EK. Disease control of uterine cervical cancer: relationships to tumor oxygen tension, vascular density, cell density, and frequency of mitosis and apoptosis measured before treatment and during radiotherapy. Clin Cancer Res. 2000;6:1104–12.

CAS  PubMed  Google Scholar 

Lally BE, Rockwell S, Fischer DB, Collingridge DR, Piepmeier JM, Knisely JP. The interactions of polarographic measurements of oxygen tension and histological grade in human glioma. Cancer J. 2006;12:461–6.

PubMed  Google Scholar 

Brown JM, Giaccia AJ. The unique physiology of solid tumors: opportunities (and problems) for cancer therapy. Cancer Res. 1998;58:1408–16.

CAS  PubMed  Google Scholar 

Kopecka J, Salaroglio IC, Perez-Ruiz E, Sarmento-Ribeiro AB, Saponara S, De Las Rivas J, et al. Hypoxia as a driver of resistance to immunotherapy. Drug Resistance Updates. 2021;59:100787.

Muz B, de la Puente P, Azab F, Azab AK. The role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapy. Hypoxia. 2015;3:83–92.

PubMed  PubMed Central  Google Scholar 

Pietrobon V, Marincola FM. Hypoxia and the phenomenon of immune exclusion. J Transl Med. 2021;19:9.

PubMed  PubMed Central  Google Scholar 

Horsman MR, Sørensen BS, Busk M, Siemann DW. Therapeutic modification of hypoxia. Clin Oncol. 2021;33:e492–e509.

CAS  Google Scholar 

Overgaard J. Hypoxic modification of radiotherapy in squamous cell carcinoma of the head and neck – A systematic review and meta-analysis. Radiother Oncol. 2011;100:22–32.

PubMed  Google Scholar 

Horsman MR, Overgaard J. The impact of hypoxia and its modification of the outcome of radiotherapy. J Radiat Res. 2016;57:i90–i8.

PubMed  PubMed Central  Google Scholar 

Horsman MR. Nicotinamide and other benzamide analogs as agents for overcoming hypoxic cell radiation resistance in tumours. A review. Acta Oncol. 1995;34:571–87.

CAS  PubMed  Google Scholar 

Janssens GO, Rademakers SE, Terhaard CH, Doornaert PA, Bijl HP, van den Ende P, et al. Accelerated radiotherapy with carbogen and nicotinamide for laryngeal cancer: results of a phase III randomized trial. J Clin Oncol. 2012;30:1777–83.

CAS  PubMed  Google Scholar 

Bernier J, Denekamp J, Rojas A, Minatel E, Horiot J, Hamers H, et al. ARCON: accelerated radiotherapy with carbogen and nicotinamide in head and neck squamous cell carcinomas. The experience of the Co-operative group of radiotherapy of the european organization for research and treatment of cancer (EORTC). Radiother Oncol. 2000;55:111–9.

CAS  PubMed  Google Scholar 

Horsman MR, Overgaard J. Hyperthermia: a potent enhancer of radiotherapy. Clin Oncol (R Coll Radio). 2007;19:418–26.

CAS  Google Scholar 

Soni S, Padwad YS. HIF-1 in cancer therapy: two decade long story of a transcription factor. Acta Oncologica. 2017;56:503–15.

CAS  PubMed  Google Scholar 

Jonasch E, Donskov F, Iliopoulos O, Rathmell WK, Narayan VK, Maughan BL, et al. Belzutifan for renal cell carcinoma in von Hippel-Lindau disease. N. Engl J Med. 2021;385:2036–46.

CAS  PubMed  PubMed Central  Google Scholar 

Cowen RL, Williams KJ, Chinje EC, Jaffar M, Sheppard FC, Telfer BA, et al. Hypoxia targeted gene therapy to increase the efficacy of tirapazamine as an adjuvant to radiotherapy: reversing tumor radioresistance and effecting cure. Cancer Res. 2004;64:1396–402.

CAS  PubMed  Google Scholar 

Marcu L, Olver I. Tirapazamine: from bench to clinical trials. Curr Clin Pharm. 2006;1:71–9.

CAS  Google Scholar 

Spiegelberg L, van Hoof SJ, Biemans R, Lieuwes NG, Marcus D, Niemans R, et al. Evofosfamide sensitizes esophageal carcinomas to radiation without increasing normal tissue toxicity. Radiother Oncol. 2019;141:247–55.

CAS  PubMed  PubMed Central  Google Scholar 

van der Wiel AMA, Jackson-Patel V, Niemans R, Yaromina A, Liu E, Marcus D, et al. Selectively targeting tumor hypoxia with the hypoxia-activated prodrug CP-506. Mol Cancer Ther. 2021;20:2372–83.

PubMed  Google Scholar 

Mistry IN, Thomas M, Calder EDD, Conway SJ, Hammond EM. Clinical advances of hypoxia-activated prodrugs in combination with radiation therapy. Int J Radiat Oncol Biol Phys. 2017;98:1183–96.

留言 (0)

沒有登入
gif